Good afternoon, hi, I'm Dr. Bill Solomon, I'm Professor of Medicine at SUNY Downstate Medical Center, and also the principal investigator of our clinical trials program, which is called the Minority Based Community Clinical Oncology Program.

I'd like to tell you that there are many, many opportunities for patients with cancer and blood diseases to undergo clinical trials and, at the present time in the United States, at most, only two percent, or one in every 50 patients who has cancer or a blood disease, undergoes a clinical trial. We hope that that number will increase because that's how we learn what the best treatments are.

And, I must tell you that the current clinical trials always feature at least the best standard treatment, and then we compare the best standard current treatment to adding an additional or new medicine to the standard treatment to see if we can even increase the response rates. So, patients should not worry that they'll be guinea pigs, because they'll at least get, when they sign up for the clinical trial, the standard best care and very likely they will actually get better care when they have the opportunity to get new medicines. And these medicines often are based on our latest findings and the understanding of the molecular biology of these tumors.

In addition, points who participate in clinical trials usually have much closer follow−up than points who don't. And, any of the experimental medicines that they get are provided for, for free. So, I would encourage anybody with a new diagnosis of cancer or blood disease to strongly ask their oncologist about the opportunities to undergo clinical trials, not only might you help yourself, but you'll help your fellowman who has a similar cancer to you.

Thank you very much for this opportunity to talk to you.